1. Home
  2. XRTX vs LXEH Comparison

XRTX vs LXEH Comparison

Compare XRTX & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • LXEH
  • Stock Information
  • Founded
  • XRTX 2011
  • LXEH 2001
  • Country
  • XRTX Canada
  • LXEH China
  • Employees
  • XRTX N/A
  • LXEH N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • LXEH Other Consumer Services
  • Sector
  • XRTX Health Care
  • LXEH Real Estate
  • Exchange
  • XRTX Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • XRTX 4.1M
  • LXEH 4.7M
  • IPO Year
  • XRTX N/A
  • LXEH 2020
  • Fundamental
  • Price
  • XRTX $1.15
  • LXEH $3.10
  • Analyst Decision
  • XRTX Strong Buy
  • LXEH
  • Analyst Count
  • XRTX 1
  • LXEH 0
  • Target Price
  • XRTX $14.00
  • LXEH N/A
  • AVG Volume (30 Days)
  • XRTX 16.7K
  • LXEH 8.0K
  • Earning Date
  • XRTX 11-15-2024
  • LXEH 09-27-2024
  • Dividend Yield
  • XRTX N/A
  • LXEH N/A
  • EPS Growth
  • XRTX N/A
  • LXEH N/A
  • EPS
  • XRTX N/A
  • LXEH N/A
  • Revenue
  • XRTX N/A
  • LXEH $5,628,870.00
  • Revenue This Year
  • XRTX N/A
  • LXEH N/A
  • Revenue Next Year
  • XRTX N/A
  • LXEH N/A
  • P/E Ratio
  • XRTX N/A
  • LXEH N/A
  • Revenue Growth
  • XRTX N/A
  • LXEH N/A
  • 52 Week Low
  • XRTX $1.09
  • LXEH $1.95
  • 52 Week High
  • XRTX $7.00
  • LXEH $65.06
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 40.84
  • LXEH 51.13
  • Support Level
  • XRTX $1.14
  • LXEH $2.26
  • Resistance Level
  • XRTX $1.25
  • LXEH $2.47
  • Average True Range (ATR)
  • XRTX 0.09
  • LXEH 0.13
  • MACD
  • XRTX 0.01
  • LXEH 0.03
  • Stochastic Oscillator
  • XRTX 10.71
  • LXEH 50.10

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: